Cross-cancer analyses demonstrate that SPP1-mediated collagen deposition, stromal fibrosis, and integrin-dependent ECM receptor signaling collectively fuel metastatic dissemination and therapy resistance. This evidence concerns the gene SPP1 and cancer.